Search

everythinglearnresearchcommunity

for

Search:↓

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Cosmetic foam product reduces hair loss and increases hair density in men.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Fetal skin has unique immune cells different from adult skin.

The hair treatment made hair grow faster and thicker and strengthened the hair roots.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Furless male rabbits grew slightly faster and heavier than furred ones, but testosterone levels were not the cause.

Salvianolic acid B promotes hair growth better than minoxidil.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

A new topical treatment using micelles shows promise for safer and more effective hair regrowth in androgenetic alopecia.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Baricitinib effectively regrows hair in severe alopecia areata cases.

The new skin model can predict how chemicals might cause skin allergies.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.